|
0
|
|
HIV Resistance to Dolutegravir Varies With Coadministered Agents.
(academic.oup.com)
|
Beck IA
…
Frenkel LM
Clinical Infectious Diseases
2026-04-30
|
#pharmacokinetics
#infection
#amr
#virulence
|
|
0
|
|
In the Mismatch: Viral Suppression Despite Low Tenofovir-Diphosphate in Dried Blood Spots in the Multicenter AIDS Cohort Study/Women's Interagency HIV Study Combined Cohort.
(academic.oup.com)
|
Mann SC
…
MaWhinney S
Clinical Infectious Diseases
2026-04-30
|
#pharmacokinetics
#viremia
#hiv
#adherence
|
|
0
|
|
Pharmacokinetics of Twice-daily Tenofovir Alafenamide in Adults With HIV-associated Tuberculosis on Bictegravir/Emtricitabine/Tenofovir Alafenamide and Rifampicin.
(academic.oup.com)
|
Osuala EC
…
Naidoo A
Clinical Infectious Diseases
2026-04-30
|
#pharmacokinetics
#hiv
#drug-drug interaction
#tb
|
|
0
|
|
When and How to Use Subcutaneous Antibiotics.
(academic.oup.com)
|
Di Bella S
…
Gatti M
Clinical Infectious Diseases
2026-04-30
|
#pharmacokinetics
#infection
#antibiotic
#drug delivery
|